333 related articles for article (PubMed ID: 24150225)
1. Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome.
Plummer JT; Evgrafov OV; Bergman MY; Friez M; Haiman CA; Levitt P; Aldinger KA
Transl Psychiatry; 2013 Oct; 3(10):e316. PubMed ID: 24150225
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
[TBL] [Abstract][Full Text] [Related]
3. The relationship of Rett syndrome and MECP2 disorders to autism.
Neul JL
Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
[TBL] [Abstract][Full Text] [Related]
4. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.
Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC
Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109
[TBL] [Abstract][Full Text] [Related]
5. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.
Nagarajan RP; Hogart AR; Gwye Y; Martin MR; LaSalle JM
Epigenetics; 2006; 1(4):e1-11. PubMed ID: 17486179
[TBL] [Abstract][Full Text] [Related]
6. Evolving role of MeCP2 in Rett syndrome and autism.
LaSalle JM; Yasui DH
Epigenomics; 2009 Oct; 1(1):119-30. PubMed ID: 20473347
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in mecp2 expression during a critical period of rat brain development.
Kurian JR; Forbes-Lorman RM; Auger AP
Epigenetics; 2007 Sep; 2(3):173-8. PubMed ID: 17965589
[TBL] [Abstract][Full Text] [Related]
8. Identification of autism-related
Wen Z; Cheng TL; Li GZ; Sun SB; Yu SY; Zhang Y; Du YS; Qiu Z
Mol Autism; 2017; 8():43. PubMed ID: 28785396
[TBL] [Abstract][Full Text] [Related]
9. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
10. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
11. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
12. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.
Liu Y; Flamier A; Bell GW; Diao AJ; Whitfield TW; Wang HC; Wu Y; Schulte F; Friesen M; Guo R; Mitalipova M; Liu XS; Vos SM; Young RA; Jaenisch R
Neuron; 2024 Jun; 112(12):1943-1958.e10. PubMed ID: 38697112
[TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
14. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Samaco RC; Hogart A; LaSalle JM
Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
17. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
18. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.
Gibson JH; Slobedman B; K N H; Williamson SL; Minchenko D; El-Osta A; Stern JL; Christodoulou J
BMC Neurosci; 2010 Apr; 11():53. PubMed ID: 20420693
[TBL] [Abstract][Full Text] [Related]
19. The role of MeCP2 in brain development and neurodevelopmental disorders.
Gonzales ML; LaSalle JM
Curr Psychiatry Rep; 2010 Apr; 12(2):127-34. PubMed ID: 20425298
[TBL] [Abstract][Full Text] [Related]
20. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]